Timothy E. Ritter

34 papers receiving 433 citations

Timothy E. Ritter's Hit Papers

Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies 2023 · 190 citations
1900+1+2Years since publication50100150

Peers

Timothy E. Ritter
Comparison fields: 5 of 71
  • Genetics 279
  • Gastroenterology 41
  • Epidemiology 215
  • Immunology 89
  • Hepatology 31
Replace Fatima Bhayat with:
Fatima Bhayat United Kingdom
Maria Weidinger Germany
Nicolas de Suray Belgium
Takahiko Toyonaga Japan
B G Feagan Canada
David J. Tsoulis Canada
Jill Fennell United Kingdom
Gaurav Syal United States
Eric Maller United States
Juan S. Lasa Argentina
Timothy E. Ritter relative to Fatima Bhayat United Kingdom Fatima Bhayat's profile →
Citations per field
00.5×7.9×
Fatima Bhayat · 1×
Citations per year

Countries citing papers authored by Timothy E. Ritter

Since Specialization
Citations

This map shows the geographic impact of Timothy E. Ritter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy E. Ritter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy E. Ritter more than expected).

Fields of papers citing papers by Timothy E. Ritter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy E. Ritter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy E. Ritter. The network helps show where Timothy E. Ritter may publish in the future.

Co-authors

The 25 scholars most cited alongside Timothy E. Ritter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Timothy E. Ritter Line = papers co-authored together Timothy E. Ritter links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies
Hit paper breakdown →
2023190
2 202032
3 202229
4 202423
5 202320
6 202220
7 202218
8 202218
9 202018
10 202512
11 202210
12 20186
13 20226
14 20245
15 20175
16 20184
17 20223
18 20193
19 20242
20 20202

About Timothy E. Ritter

Timothy E. Ritter is a scholar working on Genetics, Epidemiology, Immunology, Surgery and Infectious Diseases, having authored 38 papers that have together received 442 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (26 papers), Microscopic Colitis (20 papers), Biosimilars and Bioanalytical Methods (7 papers), Helicobacter pylori-related gastroenterology studies (5 papers), Liver Diseases and Immunity (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Clostridium difficile and Clostridium perfringens research (3 papers) and Eosinophilic Esophagitis (3 papers). The work is most often cited by research in Genetics (279 citations), Gastroenterology (41 citations), Epidemiology (215 citations), Immunology (89 citations) and Hepatology (31 citations). Timothy E. Ritter has collaborated with scholars based in United States, Italy and Belgium. Frequent co-authors include Brian G. Feagan, Silvio Danese, Douglas C. Wolf, Bruce E. Sands, Laurent Peyrin‐Biroulet, William J. Sandborn, Marla C. Dubinsky, Stefan Schreiber, Séverine Vermeire and Sheldon Sloan. Their work appears in journals such as The American Journal of Gastroenterology, Inflammatory Bowel Diseases, Gastroenterology, Journal of Crohn s and Colitis and Open Forum Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact